Ipca Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	5,646	1,672	2,089	12,579	2,752
Short-Term Investments	6,334	1,745	851.3	5,950	3,657
Trading Asset Securities	-	7,634	5,584	3,233	7,193
Cash & Short-Term Investments	11,980	11,051	8,524	21,761	13,602
Cash Growth	8.41%	29.63%	-60.83%	59.98%	79.24%
Accounts Receivable	20,143	18,841	16,946	9,961	9,180
Other Receivables	-	2,568	2,012	1,865	2,088
Receivables	20,641	21,837	19,052	11,859	11,372
Inventory	27,310	25,604	24,713	17,434	18,580
Prepaid Expenses	-	573.1	482.9	311.9	188.6
Other Current Assets	3,838	3,620	2,617	527.1	829.7
Total Current Assets	63,769	62,685	55,389	51,893	44,572
Property, Plant & Equipment	52,022	46,851	46,631	26,946	25,026
Long-Term Investments	2,101	2,163	3,036	3,027	2,699
Goodwill	828.1	905.8	905.8	381.4	388.4
Other Intangible Assets	1,148	1,127	1,426	1,591	1,672
Long-Term Deferred Tax Assets	205.4	169.2	42.3	35.7	20.2
Other Long-Term Assets	3,484	3,381	2,697	1,232	1,144
Total Assets	123,702	117,606	111,013	86,264	76,235
Accounts Payable	9,403	8,462	7,761	5,251	5,577
Accrued Expenses	-	3,216	3,800	2,051	2,278
Short-Term Debt	5,948	4,953	5,592	6,618	3,678
Current Portion of Long-Term Debt	-	2,632	2,479	1,439	282.5
Current Portion of Leases	179.3	101.4	109.3	66.6	44.8
Current Income Taxes Payable	587.8	575	462	253.2	183.3
Current Unearned Revenue	-	154.7	168.7	274	267.7
Other Current Liabilities	6,951	3,769	3,184	2,105	2,347
Total Current Liabilities	23,069	23,862	23,556	18,058	14,659
Long-Term Debt	1,091	5,432	5,804	6,518	3,952
Long-Term Leases	868.9	509	399.3	170.8	115
Long-Term Unearned Revenue	-	-	1.2	2.8	4.3
Pension & Post-Retirement Benefits	-	119.5	89.7	16.7	13.9
Long-Term Deferred Tax Liabilities	2,449	2,950	3,105	1,892	1,644
Other Long-Term Liabilities	983.3	850	787.4	453.2	430.1
Total Liabilities	28,461	33,723	33,743	27,111	20,818
Common Stock	253.7	253.7	253.7	253.7	253.7
Additional Paid-In Capital	-	965.2	965.2	965.2	965.2
Retained Earnings	-	68,424	62,104	57,151	53,471
Comprehensive Income & Other	80,384	-158.2	-1	50.7	-41.6
Total Common Equity	80,638	69,485	63,322	58,420	54,648
Minority Interest	14,603	14,398	13,948	733	769.2
Shareholders' Equity	95,241	83,883	77,270	59,153	55,418
Total Liabilities & Equity	123,702	117,606	111,013	86,264	76,235
Total Debt	8,088	13,627	14,384	14,813	8,072
Net Cash (Debt)	3,893	-2,577	-5,859	6,949	5,530
Net Cash Growth	-	-	-	25.65%	12.06%
Net Cash Per Share	15.34	-10.16	-23.09	27.39	21.80
Filing Date Shares Outstanding	253.66	253.7	253.7	253.7	253.7
Total Common Shares Outstanding	253.66	253.7	253.7	253.7	253.7
Working Capital	40,699	38,823	31,833	33,835	29,913
Book Value Per Share	317.89	273.88	249.59	230.27	215.40
Tangible Book Value	78,662	67,452	60,990	56,448	52,588
Tangible Book Value Per Share	310.10	265.87	240.40	222.49	207.28
Land	-	3,075	6,425	2,145	2,157
Buildings	-	14,432	13,569	8,175	7,140
Machinery	-	46,700	43,737	29,454	24,473
Construction In Progress	-	6,162	3,236	1,222	2,939
Leasehold Improvements	-	-	-	7.9	-